Name: CG Oncology, Inc. (CGON) Balance Sheet
Creator: FinSpry

CG Oncology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for CG Oncology, Inc. (CGON) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	257.07	8.27	88.14	53.61
Short-Term Investments	484.93	179.41	55.34	0.00
Cash & Short-Term Investments	742.00	187.67	143.48	53.61
Accounts Receivable	0.78	0.09	0.30	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	11.43	6.36	3.42	4.80
Total Current Assets	754.21	194.12	147.21	58.41
Non-Current Assets
Property, Plant & Equipment (Net)	0.49	0.49	0.51	0.20
Other Non-Current Assets	0.09	0.02	0.03	0.09
Total Non-Current Assets	0.59	5.18	0.54	0.29
Total Assets	754.80	199.30	147.75	58.69
Current Liabilities
Accounts Payable	6.52	3.24	0.99	1.00
Short-Term Debt	0.37	0.00	8.97	2.94
Current Portion of Long-Term Debt	0.00	0.00	8.97	2.94
Accrued Liabilities	8.44	6.51	5.12	1.89
Other Current Liabilities	0.44	0.45	0.17	0.07
Total Current Liabilities	21.37	14.25	15.43	5.98
Non-Current Liabilities
Long-Term Debt	0.05	0.24	6.53	12.06
Other Non-Current Liabilities	0.00	0.01	0.35	0.35
Total Non-Current Liabilities	0.05	0.26	7.14	12.47
Total Liabilities	21.42	14.51	22.57	18.44
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00
Retained Earnings	-217.98	-129.94	-81.34	-45.89
Additional Paid-in Capital	951.35	6.84	3.64	3.27
Shares Outstanding	76.15	63.48	63.48	63.48
Total Stockholders' Equity	733.38	184.79	125.18	40.25
Total Liabilities & Equity	754.80	199.30	147.75	58.69